Literature DB >> 6979709

Persistent polyclonal lymphocytosis of B lymphocytes.

D S Gordon, B M Jones, S W Browning, T J Spira, D N Lawrence.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6979709     DOI: 10.1056/NEJM198207223070407

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

1.  Persistent polyclonal B-cell lymphocytosis: extensively proliferated CD27+IgM+IgD+ memory B cells with a distinctive immunophenotype.

Authors:  M A Berkowska; C Grosserichter-Wagener; H J Adriaansen; D de Ridder; K P Mirani-Oostdijk; H J Agteresch; S Böttcher; A Orfao; J J M van Dongen; M C van Zelm
Journal:  Leukemia       Date:  2014-02-19       Impact factor: 11.528

2.  Long-term follow-up of 111 patients with persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes.

Authors:  E Cornet; J F Lesesve; H Mossafa; G Sébahoun; V Levy; F Davi; X Troussard
Journal:  Leukemia       Date:  2008-07-31       Impact factor: 11.528

3.  Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.

Authors:  Falko Fend; José Cabecadas; Philippe Gaulard; Elaine S Jaffe; Philip Kluin; Isinsu Kuzu; Loann Peterson; Andrew Wotherspoon; Christer Sundström
Journal:  J Hematop       Date:  2012-09       Impact factor: 0.196

4.  B-cell signaling in persistent polyclonal B lymphocytosis (PPBL).

Authors:  Nadine Voelxen; Claudia Wehr; Sylvia Gutenberger; Baerbel Keller; Miriam Erlacher; Cecilia Dominguez-Conde; Daniela Bertele; Florian Emmerich; Milena Pantic; Stefanie Jennings; Mirzokhid Rakhmanov; Christian Foerster; Uwe M Martens; Uwe Platzbecker; Hans-Hartmut Peter; Paul Fisch; Kaan Boztug; Hermann Eibel; Ulrich Salzer; Klaus Warnatz
Journal:  Immunol Cell Biol       Date:  2016-04-29       Impact factor: 5.126

5.  Downregulation of interferon alpha but not gamma receptor expression in vivo in the acquired immunodeficiency syndrome.

Authors:  A S Lau; S E Read; B R Williams
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

6.  HLA phenotype and insulin antibody production.

Authors:  W G Reeves; K Gelsthorpe; P Van der Minne; R Torensma; R B Tattersall
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

Review 7.  [In situ lymphoma and other early stage malignant non-Hodgkin lymphomas].

Authors:  L Quintanilla-Martínez; P Adam; F Fend
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

8.  Factors governing the human immune response to injected insulin.

Authors:  W G Reeves; D Barr; C A Douglas; K Gelsthorpe; I Hanning; A Skene; L Wells; R M Wilson; R B Tattersall
Journal:  Diabetologia       Date:  1984-04       Impact factor: 10.122

9.  [Asymptomatic 32 year old female smoker with persistent polyclonal lymphocytosis].

Authors:  B Chapuy; G Wulf; H W Tessen; F Griesinger; L Trümper; R Schroers
Journal:  Internist (Berl)       Date:  2007-03       Impact factor: 0.743

Review 10.  When 2+2=5: the origins and fates of aneuploid and tetraploid cells.

Authors:  Randall W King
Journal:  Biochim Biophys Acta       Date:  2008-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.